Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F91WS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $194,907
Award facts
- Contract value 100% obligated
- $194,906.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $194,906.56 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Entresto 24 mg–26 mg tablets (180-count units). This is a firm fixed-price contract with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of January 9, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
This delivery order is issued under the broader DLA Troop Support Medical IDC valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The IDC covers specialty medications, brand-name and generic drugs, vaccines, and various medical supplies across multiple therapeutic domains. Entresto, a cardiovascular medication used primarily for heart failure treatment, is being procured to support Defense Health Agency requirements and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F91WS?
SPE2DR26F91WS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F91WS worth?
The government has obligated $194,907 on SPE2DR26F91WS.
Is contract SPE2DR26F91WS an order under another contract?
Yes. SPE2DR26F91WS is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91WS competed?
The extent of competition for SPE2DR26F91WS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award